Abstract P3-14-04: Effects of the dual selective CYP17 lyase inhibitor and androgen receptor (AR) antagonist, VT-464, on AR+ and ER+ tumor models in vitro and in vivo


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ellison, SJ; Norris, JD; Wardell, S; Eisner, JR; Hoekstra, WJ; Stagg, DB; Alley, HM; Moore, WR; McDonnell, DP

Published Date

  • February 15, 2016

Published In

  • Poster Session Abstracts

Published By

Digital Object Identifier (DOI)

  • 10.1158/1538-7445.sabcs15-p3-14-04

Conference Name

  • Abstracts: Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 8-12, 2015; San Antonio, TX